Global Orally Disintegrating Tablet Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Orally Disintegrating Tablet market size will reach 21,251 Million USD in 2025 and is projected to reach 47,599 Million USD by 2032, with a CAGR of 12.21% (2025-2032). Notably, the China Orally Disintegrating Tablet market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Orally disintegrating tablets (ODTs) are pharmaceutical dosage forms designed to disintegrate or dissolve rapidly in the mouth without the need for water or chewing. These tablets offer a convenient and user-friendly method of administering medications, particularly for individuals who have difficulty swallowing traditional tablets or capsules. ODTs are commonly used for a wide range of medications, including pain relievers, antihistamines, and medications for conditions like allergies or epilepsy. The tablets disintegrate quickly in saliva, allowing for rapid absorption of the active ingredient through the oral mucosa, which can lead to faster onset of action. ODTs have found wide acceptance in both pediatric and geriatric patient populations, as well as among individuals with compliance issues, making them a valuable option in pharmaceutical formulations.
The major global manufacturers of Orally Disintegrating Tablet include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Otsuka, Conquer, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Orally Disintegrating Tablet. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Orally Disintegrating Tablet market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Orally Disintegrating Tablet market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Orally Disintegrating Tablet industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Orally Disintegrating Tablet Include:
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Bristol-Myers Squibb
Eli Lilly and Company
AstraZeneca
Otsuka
Conquer
Orally Disintegrating Tablet Product Segment Include:
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Orally Disintegrating Tablet Product Application Include:
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Orally Disintegrating Tablet Industry PESTEL Analysis
Chapter 3: Global Orally Disintegrating Tablet Industry Porter's Five Forces Analysis
Chapter 4: Global Orally Disintegrating Tablet Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Orally Disintegrating Tablet Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Orally Disintegrating Tablet Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Orally Disintegrating Tablet Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Orally Disintegrating Tablet market size will reach 21,251 Million USD in 2025 and is projected to reach 47,599 Million USD by 2032, with a CAGR of 12.21% (2025-2032). Notably, the China Orally Disintegrating Tablet market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Orally disintegrating tablets (ODTs) are pharmaceutical dosage forms designed to disintegrate or dissolve rapidly in the mouth without the need for water or chewing. These tablets offer a convenient and user-friendly method of administering medications, particularly for individuals who have difficulty swallowing traditional tablets or capsules. ODTs are commonly used for a wide range of medications, including pain relievers, antihistamines, and medications for conditions like allergies or epilepsy. The tablets disintegrate quickly in saliva, allowing for rapid absorption of the active ingredient through the oral mucosa, which can lead to faster onset of action. ODTs have found wide acceptance in both pediatric and geriatric patient populations, as well as among individuals with compliance issues, making them a valuable option in pharmaceutical formulations.
The major global manufacturers of Orally Disintegrating Tablet include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Bristol-Myers Squibb, Eli Lilly and Company, AstraZeneca, Otsuka, Conquer, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Orally Disintegrating Tablet. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Orally Disintegrating Tablet market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Orally Disintegrating Tablet market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Orally Disintegrating Tablet industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Orally Disintegrating Tablet Include:
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Bristol-Myers Squibb
Eli Lilly and Company
AstraZeneca
Otsuka
Conquer
Orally Disintegrating Tablet Product Segment Include:
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Orally Disintegrating Tablet Product Application Include:
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Orally Disintegrating Tablet Industry PESTEL Analysis
Chapter 3: Global Orally Disintegrating Tablet Industry Porter's Five Forces Analysis
Chapter 4: Global Orally Disintegrating Tablet Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Orally Disintegrating Tablet Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Orally Disintegrating Tablet Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Orally Disintegrating Tablet Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Orally Disintegrating Tablet Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Orally Disintegrating Tablet Product by Type
- 1.2.1 Anti-Psychotics Drug
- 1.2.2 Anti-Epileptics Drug
- 1.2.3 Others
- 1.3 Orally Disintegrating Tablet Product by Application
- 1.3.1 CNS Diseases
- 1.3.2 Gastrointestinal Diseases
- 1.3.3 CVS Diseases
- 1.3.4 Others
- 1.4 Global Orally Disintegrating Tablet Market Revenue and Sales Analysis
- 1.4.1 Global Orally Disintegrating Tablet Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Orally Disintegrating Tablet Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Orally Disintegrating Tablet Market Sales Price Trend Analysis (2020-2032)
- 1.5 Orally Disintegrating Tablet Market Development Status and Trends
- 1.5.1 Orally Disintegrating Tablet Industry Development Status Analysis
- 1.5.2 Orally Disintegrating Tablet Industry Development Trends Analysis
- 2 Orally Disintegrating Tablet Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Orally Disintegrating Tablet Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Orally Disintegrating Tablet Market Analysis by Country
- 4.1 Global Orally Disintegrating Tablet Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Orally Disintegrating Tablet Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Orally Disintegrating Tablet Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Orally Disintegrating Tablet Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Orally Disintegrating Tablet Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Orally Disintegrating Tablet Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Orally Disintegrating Tablet Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Orally Disintegrating Tablet Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Orally Disintegrating Tablet Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Orally Disintegrating Tablet Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Orally Disintegrating Tablet Average Sales Price by Manufacturers (2021-2025)
- 5.2 Orally Disintegrating Tablet Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Orally Disintegrating Tablet Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Orally Disintegrating Tablet Market Analysis by Type
- 6.1 Global Orally Disintegrating Tablet Market Revenue Analysis by Type
- 6.1.1 Global Orally Disintegrating Tablet Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Orally Disintegrating Tablet Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Orally Disintegrating Tablet Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Orally Disintegrating Tablet Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Teva
- 7.1.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Teva Orally Disintegrating Tablet Product Portfolio
- 7.1.3 Teva Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Merck
- 7.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Merck Orally Disintegrating Tablet Product Portfolio
- 7.2.3 Merck Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Mylan
- 7.3.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Mylan Orally Disintegrating Tablet Product Portfolio
- 7.3.3 Mylan Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Pfizer
- 7.4.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Pfizer Orally Disintegrating Tablet Product Portfolio
- 7.4.3 Pfizer Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Johnson and Johnson
- 7.5.1 Johnson and Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Johnson and Johnson Orally Disintegrating Tablet Product Portfolio
- 7.5.3 Johnson and Johnson Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 GSK
- 7.6.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 GSK Orally Disintegrating Tablet Product Portfolio
- 7.6.3 GSK Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Bristol-Myers Squibb
- 7.7.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Bristol-Myers Squibb Orally Disintegrating Tablet Product Portfolio
- 7.7.3 Bristol-Myers Squibb Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Eli Lilly and Company
- 7.8.1 Eli Lilly and Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Eli Lilly and Company Orally Disintegrating Tablet Product Portfolio
- 7.8.3 Eli Lilly and Company Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 AstraZeneca
- 7.9.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 AstraZeneca Orally Disintegrating Tablet Product Portfolio
- 7.9.3 AstraZeneca Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Otsuka
- 7.10.1 Otsuka Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Otsuka Orally Disintegrating Tablet Product Portfolio
- 7.10.3 Otsuka Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 Conquer
- 7.11.1 Conquer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Conquer Orally Disintegrating Tablet Product Portfolio
- 7.11.3 Conquer Orally Disintegrating Tablet Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Orally Disintegrating Tablet Industry Chain Analysis
- 8.2 Orally Disintegrating Tablet Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Orally Disintegrating Tablet Product Downstream Application Analysis
- 8.3.1 Global Orally Disintegrating Tablet Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Orally Disintegrating Tablet Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Orally Disintegrating Tablet Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Orally Disintegrating Tablet Typical Downstream Customers
- 8.5 Orally Disintegrating Tablet Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
